Opportunities for an atherosclerosis vaccine: From mice to humans
- 19 January 2020
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 38 (28), 4495-4506
- https://doi.org/10.1016/j.vaccine.2019.12.039
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Characterization of Resident B Cells of Vascular Walls in Human Atherosclerotic PatientsThe Journal of Immunology, 2013
- Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesionsJournal of Autoimmunity, 2012
- Cytokine Therapy With Interleukin-2/Anti–Interleukin-2 Monoclonal Antibody Complexes Expands CD4+CD25+Foxp3+ Regulatory T Cells and Attenuates Development and Progression of AtherosclerosisCirculation, 2012
- Dynamic Changes in Regulatory T Cells Are Linked to Levels of Diet-Induced HypercholesterolemiaCirculation, 2011
- T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouseThe Journal of Experimental Medicine, 2011
- Heat Shock Protein 60 and Immune Inflammatory Responses in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Safety and efficacy trial of adipose-tissue derived oral preparation V-6 Immunitor (V-6): results of open-label, two-month, follow-up studyLipids in Health and Disease, 2010
- Immune and Inflammatory Mechanisms of AtherosclerosisAnnual Review of Immunology, 2009
- Effect of immunization against ox-LDL with two different antigens on formation and development of atherosclerosisLipids in Health and Disease, 2007
- Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (−/−) miceBiochemical and Biophysical Research Communications, 2005